Literature DB >> 28807110

How similar are the treatment responses to biosimilars in patients with psoriasis? A systematic review of statistical margins in comparative clinical trials.

Marilyn T Wan1, Bruce E Strober2, Jashin J Wu3, Daniel B Shin1, Joel M Gelfand4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28807110      PMCID： PMC5605927          DOI： 10.1016/j.jaad.2017.05.032

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

Review 1.  Biosimilars for psoriasis: preclinical analytical assessment to determine similarity.

Authors:  A Blauvelt; A D Cohen; L Puig; R Vender; J van der Walt; J J Wu
Journal:  Br J Dermatol       Date:  2015-12-30       Impact factor: 9.302

Review 2.  Biosimilars for psoriasis: clinical studies to determine similarity.

Authors:  A Blauvelt; L Puig; S Chimenti; R Vender; M Rajagopalan; R Romiti; L Skov; C Zachariae; H Young; E Prens; A Cohen; J van der Walt; J J Wu
Journal:  Br J Dermatol       Date:  2017-05-28       Impact factor: 9.302

Review 3.  Biopharmaceuticals and biosimilars in psoriasis: what the dermatologist needs to know.

Authors:  Bruce E Strober; Katherine Armour; Ricardo Romiti; Catherine Smith; Paul W Tebbey; Alan Menter; Craig Leonardi
Journal:  J Am Acad Dermatol       Date:  2012-02       Impact factor: 11.527
  3 in total
  1 in total

Review 1.  Assessing the compliance of systematic review articles published in leading dermatology journals with the PRISMA statement guidelines: A systematic review.

Authors:  Buket Gundogan; Naeem Dowlut; Shivanchan Rajmohan; Mimi R Borrelli; Mirabel Millip; Christos Iosifidis; Yagazie Z Udeaja; Ginimol Mathew; Alexander Fowler; Riaz Agha
Journal:  JAAD Int       Date:  2020-09-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.